Skip to content

Clinical trials

Phase 2 Crohn Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 2 Country / region: Canada Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20043
20053
20063
20072
20081
20091
20102
20117
20125
20131
20153
20165
20172
20183
20213
20224
20231
20245
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated18
Recruiting7
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
AbbVie5
Amgen4
Shire4
AstraZeneca3
Eli Lilly and Company3
Janssen Research & Development, LLC3
Bristol-Myers Squibb2
Centocor, Inc.2
Takeda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease63
Inflammatory Bowel Diseases10
Colitis, Ulcerative8
Inflammation5
Colitis1
Digestive System Diseases1
Gastrointestinal Diseases1
Intestinal Diseases1
Irritable Bowel Syndrome1
Lymphoma, Follicular1

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.